Tower View Wealth Management’s Biogen BIIB Stock Holding History

Tower View Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.27K	Hold	29	–	–	﹤0.01%	173
2026 Q1	$5.32K	Hold	29	–	–	﹤0.01%	172
2025 Q4	$5.1K	Hold	29	–	–	﹤0.01%	156
2025 Q3	$4.06K	Hold	29	–	–	﹤0.01%	157
2025 Q2	$3.64K	Hold	29	–	–	﹤0.01%	179
2025 Q1	$3.97K	Hold	29	–	–	﹤0.01%	165
2024 Q4	$4.43K	Hold	29	–	–	﹤0.01%	159
2024 Q3	$5.62K	Hold	29	–	–	﹤0.01%	156
2024 Q2	$6.72K	Hold	29	–	–	﹤0.01%	145
2024 Q1	$6.25K	Hold	29	–	–	﹤0.01%	151
2023 Q4	$8K	Hold	29	–	–	0.01%	129
2023 Q3	$7K	Hold	29	–	–	﹤0.01%	127
2023 Q2	$8K	Hold	29	–	–	0.01%	126
2023 Q1	$8K	Hold	29	–	–	0.01%	120
2022 Q4	$8K	Hold	29	–	–	0.01%	125
2022 Q3	$8K	Hold	29	–	–	0.01%	123
2022 Q2	$6K	Hold	29	–	–	﹤0.01%	130
2022 Q1	$6K	Hold	29	–	–	﹤0.01%	159
2021 Q4	$7K	Hold	29	–	–	﹤0.01%	164
2021 Q3	$8K	Hold	29	–	–	﹤0.01%	190
2021 Q2	$10K	Hold	29	–	–	0.01%	131
2021 Q1	$8K	Hold	29	–	–	﹤0.01%	140
2020 Q4	$7K	Hold	29	–	–	﹤0.01%	146
2020 Q3	$8K	Hold	29	–	–	0.01%	117
2020 Q2	$8K	Hold	29	–	–	0.01%	108
2020 Q1	$9K	Hold	29	–	–	0.01%	91
2019 Q4	$9K	Hold	29	–	–	0.01%	116
2019 Q3	$7K	Hold	29	–	–	0.01%	115
2019 Q2	$7K	Hold	29	–	–	0.01%	111
2019 Q1	$7K	Hold	29	–	–	0.01%	118
2018 Q4	$9K	Hold	29	–	–	0.01%	111
2018 Q3	$10K	Buy	+29	New	+$9.98K	0.01%	128

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tower View Wealth Management's BIIB Position: Q2 2026 in Review

Tower View Wealth Management held its Biogen (BIIB) position steady in Q2 2026 at 29 shares worth $6.27K. The position accounts for ﹤0.01% of the portfolio, ranked #173.

Tower View Wealth Management first reported a position in BIIB in Q3 2018 and has held it in 32 quarters since. The position peaked at $10K in Q2 2021. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Tower View Wealth Management held 29 shares of Biogen worth $6.27K as of Q2 2026.
Tower View Wealth Management left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Tower View Wealth Management's portfolio in Q2 2026, its #173 holding.
Tower View Wealth Management first reported a position in Biogen in Q3 2018 and has held it in 32 quarters since.
Tower View Wealth Management's Biogen position peaked at $10K in Q2 2021.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Tower View Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.